US Stock MarketDetailed Quotes

BMY Bristol-Myers Squibb

Watchlist

44.842
-0.008-0.02%

Trading Apr 29 11:50 ET

90.90BMarket Cap-14465P/E (TTM)

Bristol-Myers Squibb Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-4.58%2.83B

6.08%13.86B

28.61%4.25B

28.86%4.75B

-16.54%1.89B

-22.09%2.97B

-19.38%13.07B

-18.51%3.31B

-29.98%3.69B

-26.11%2.26B

Net income from continuing operations

-625.28%-11.91B

26.71%8.04B

-12.99%1.76B

20.27%1.93B

45.35%2.08B

76.70%2.27B

-9.54%6.35B

-14.63%2.03B

3.61%1.61B

34.68%1.43B

Operating gains losses

-879.49%-382M

-176.34%-724M

26.96%-298M

-14.43%-222M

-298.80%-165M

-115.18%-39M

81.67%-262M

-265.18%-408M

68.96%-194M

125.46%83M

Depreciation and amortization

4.24%2.53B

-5.02%9.76B

-2.26%2.46B

-5.91%2.44B

-5.85%2.43B

-6.00%2.43B

-3.84%10.28B

-2.25%2.52B

-5.10%2.59B

-4.76%2.58B

Deferred tax

-29.74%-711M

-20.09%-3.29B

-112.66%-1.33B

49.30%-327M

-38.87%-1.09B

20.23%-548M

-96.55%-2.74B

50.71%-624M

-1,915.63%-645M

-379.75%-782M

Other non cash items

16,318.99%12.97B

16.86%1.21B

566.67%640M

3,590.00%349M

-60.06%145M

-86.59%79M

29.75%1.04B

166.67%96M

-104.17%-10M

-54.34%363M

Change In working capital

114.56%198M

14.13%-1.91B

286.68%855M

77.44%291M

-8.07%-1.7B

-275.69%-1.36B

-76.76%-2.23B

-676.27%-458M

-74.73%164M

-11.09%-1.57B

-Change in receivables

373.71%479M

-50.08%-995M

-379.25%-508M

63.35%-247M

90.28%-65M

-122.26%-175M

37.10%-663M

36.90%-106M

-159.23%-674M

3.46%-669M

-Change in inventory

22.70%-218M

-988.41%-751M

-380.49%-197M

-1,500.00%-256M

-23.08%-16M

-28,300.00%-282M

-630.77%-69M

67.97%-41M

-153.33%-16M

-360.00%-13M

-Change in payables and accrued expense

12.98%1.21B

69.18%-405M

310.17%1.49B

-183.33%-680M

-87.21%-2.28B

25.41%1.07B

-60.64%-1.31B

-17,800.00%-708M

-29.73%-240M

-4.54%-1.22B

-Change in other working capital

35.51%-1.27B

229.51%237M

-81.86%72M

34.73%1.47B

102.13%665M

1.45%-1.97B

-130.60%-183M

70.39%397M

2.82%1.09B

-25.06%329M

Cash from discontinued investing activities

Operating cash flow

-4.58%2.83B

6.08%13.86B

28.61%4.25B

28.86%4.75B

-16.54%1.89B

-22.09%2.97B

-19.38%13.07B

-18.51%3.31B

-29.98%3.69B

-26.11%2.26B

Investing cash flow

Cash flow from continuing investing activities

-9,241.90%-19.62B

-116.10%-2.3B

-210.96%-1.35B

80.30%-410M

-13.84%-329M

-321.05%-210M

-97.40%-1.06B

202.49%1.21B

-113.22%-2.08B

-260.56%-289M

Capital expenditure reported

-2.16%-284M

-8.14%-1.21B

4.62%-330M

-38.46%-342M

4.78%-259M

-9.88%-278M

-14.90%-1.12B

-8.13%-346M

8.52%-247M

-29.52%-272M

Net business purchase and sale

-13,396.64%-19.81B

91.28%-260M

-190.91%-340M

97.40%-79M

103.64%10M

472.50%149M

-245.82%-2.98B

1,338.46%374M

-249.83%-3.04B

-67.68%-275M

Net investment purchase and sale

690.12%478M

-127.20%-826M

-157.05%-676M

-99.09%11M

-131.01%-80M

-120.88%-81M

134.16%3.04B

70.50%1.19B

639.88%1.21B

-53.43%258M

Cash from discontinued investing activities

Investing cash flow

-9,241.90%-19.62B

-116.10%-2.3B

-210.96%-1.35B

80.30%-410M

-13.84%-329M

-321.05%-210M

-97.40%-1.06B

202.49%1.21B

-113.22%-2.08B

-260.56%-289M

Financing cash flow

Cash flow from continuing financing activities

580.13%14.64B

44.49%-9.42B

129.79%967M

-13.58%-5.16B

38.27%-2.17B

46.05%-3.05B

-4.55%-16.96B

18.17%-3.25B

-155.22%-4.54B

-10.62%-3.52B

Net issuance payments of debt

1,155.09%15.95B

108.59%456M

1,445.59%2.1B

99.65%-10M

95.55%-124M

-859.80%-1.51B

14.09%-5.31B

219.30%136M

-691.41%-2.86B

-148.35%-2.79B

Net common stock issuance

--0

35.57%-5.16B

--0

-583.76%-4B

---905M

95.00%-250M

-27.26%-8B

12.18%-2.42B

-11.43%-585M

--0

Cash dividends paid

-1.34%-1.21B

-2.37%-4.74B

-1.31%-1.16B

-3.21%-1.19B

-4.09%-1.2B

-0.93%-1.2B

-5.41%-4.63B

-4.19%-1.15B

-5.87%-1.15B

-4.64%-1.15B

Proceeds from stock option exercised by employees

-5.43%-97M

-97.26%27M

-86.03%25M

-22.64%41M

-87.35%53M

-127.63%-92M

53.51%984M

--179M

--53M

--419M

Cash from discontinued financing activities

Financing cash flow

580.13%14.64B

44.49%-9.42B

129.79%967M

-13.58%-5.16B

38.27%-2.17B

46.05%-3.05B

-4.55%-16.96B

18.17%-3.25B

-155.22%-4.54B

-10.62%-3.52B

Net cash flow

Beginning cash position

23.53%11.52B

-34.86%9.33B

-4.89%7.57B

-23.13%8.43B

-28.07%9.05B

-34.86%9.33B

-4.39%14.32B

-42.67%7.96B

-3.83%10.96B

11.11%12.58B

Current changes in cash

-637.93%-2.14B

143.34%2.15B

204.24%3.87B

72.11%-819M

60.27%-615M

83.39%-290M

-793.33%-4.96B

159.27%1.27B

-217.01%-2.94B

-2,768.97%-1.55B

Effect of exchange rate changes

-446.15%-45M

236.36%45M

-17.89%78M

42.42%-38M

88.73%-8M

44.44%13M

67.65%-33M

275.93%95M

-135.71%-66M

-494.44%-71M

End cash Position

3.16%9.33B

23.53%11.52B

-4.89%7.57B

-23.13%8.43B

-28.07%9.05B

-34.86%9.33B

-42.67%7.96B

-3.83%10.96B

Free cash flow

-5.27%2.55B

5.88%12.65B

32.50%3.92B

28.17%4.41B

-18.15%1.63B

-24.36%2.69B

-21.57%11.95B

-20.79%2.96B

-31.14%3.44B

-30.21%1.99B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-4.58%2.83B	6.08%13.86B	28.61%4.25B	28.86%4.75B	-16.54%1.89B	-22.09%2.97B	-19.38%13.07B	-18.51%3.31B	-29.98%3.69B	-26.11%2.26B
Net income from continuing operations	-625.28%-11.91B	26.71%8.04B	-12.99%1.76B	20.27%1.93B	45.35%2.08B	76.70%2.27B	-9.54%6.35B	-14.63%2.03B	3.61%1.61B	34.68%1.43B
Operating gains losses	-879.49%-382M	-176.34%-724M	26.96%-298M	-14.43%-222M	-298.80%-165M	-115.18%-39M	81.67%-262M	-265.18%-408M	68.96%-194M	125.46%83M
Depreciation and amortization	4.24%2.53B	-5.02%9.76B	-2.26%2.46B	-5.91%2.44B	-5.85%2.43B	-6.00%2.43B	-3.84%10.28B	-2.25%2.52B	-5.10%2.59B	-4.76%2.58B
Deferred tax	-29.74%-711M	-20.09%-3.29B	-112.66%-1.33B	49.30%-327M	-38.87%-1.09B	20.23%-548M	-96.55%-2.74B	50.71%-624M	-1,915.63%-645M	-379.75%-782M
Other non cash items	16,318.99%12.97B	16.86%1.21B	566.67%640M	3,590.00%349M	-60.06%145M	-86.59%79M	29.75%1.04B	166.67%96M	-104.17%-10M	-54.34%363M
Change In working capital	114.56%198M	14.13%-1.91B	286.68%855M	77.44%291M	-8.07%-1.7B	-275.69%-1.36B	-76.76%-2.23B	-676.27%-458M	-74.73%164M	-11.09%-1.57B
-Change in receivables	373.71%479M	-50.08%-995M	-379.25%-508M	63.35%-247M	90.28%-65M	-122.26%-175M	37.10%-663M	36.90%-106M	-159.23%-674M	3.46%-669M
-Change in inventory	22.70%-218M	-988.41%-751M	-380.49%-197M	-1,500.00%-256M	-23.08%-16M	-28,300.00%-282M	-630.77%-69M	67.97%-41M	-153.33%-16M	-360.00%-13M
-Change in payables and accrued expense	12.98%1.21B	69.18%-405M	310.17%1.49B	-183.33%-680M	-87.21%-2.28B	25.41%1.07B	-60.64%-1.31B	-17,800.00%-708M	-29.73%-240M	-4.54%-1.22B
-Change in other working capital	35.51%-1.27B	229.51%237M	-81.86%72M	34.73%1.47B	102.13%665M	1.45%-1.97B	-130.60%-183M	70.39%397M	2.82%1.09B	-25.06%329M
Cash from discontinued investing activities
Operating cash flow	-4.58%2.83B	6.08%13.86B	28.61%4.25B	28.86%4.75B	-16.54%1.89B	-22.09%2.97B	-19.38%13.07B	-18.51%3.31B	-29.98%3.69B	-26.11%2.26B
Investing cash flow
Cash flow from continuing investing activities	-9,241.90%-19.62B	-116.10%-2.3B	-210.96%-1.35B	80.30%-410M	-13.84%-329M	-321.05%-210M	-97.40%-1.06B	202.49%1.21B	-113.22%-2.08B	-260.56%-289M
Capital expenditure reported	-2.16%-284M	-8.14%-1.21B	4.62%-330M	-38.46%-342M	4.78%-259M	-9.88%-278M	-14.90%-1.12B	-8.13%-346M	8.52%-247M	-29.52%-272M
Net business purchase and sale	-13,396.64%-19.81B	91.28%-260M	-190.91%-340M	97.40%-79M	103.64%10M	472.50%149M	-245.82%-2.98B	1,338.46%374M	-249.83%-3.04B	-67.68%-275M
Net investment purchase and sale	690.12%478M	-127.20%-826M	-157.05%-676M	-99.09%11M	-131.01%-80M	-120.88%-81M	134.16%3.04B	70.50%1.19B	639.88%1.21B	-53.43%258M
Cash from discontinued investing activities
Investing cash flow	-9,241.90%-19.62B	-116.10%-2.3B	-210.96%-1.35B	80.30%-410M	-13.84%-329M	-321.05%-210M	-97.40%-1.06B	202.49%1.21B	-113.22%-2.08B	-260.56%-289M
Financing cash flow
Cash flow from continuing financing activities	580.13%14.64B	44.49%-9.42B	129.79%967M	-13.58%-5.16B	38.27%-2.17B	46.05%-3.05B	-4.55%-16.96B	18.17%-3.25B	-155.22%-4.54B	-10.62%-3.52B
Net issuance payments of debt	1,155.09%15.95B	108.59%456M	1,445.59%2.1B	99.65%-10M	95.55%-124M	-859.80%-1.51B	14.09%-5.31B	219.30%136M	-691.41%-2.86B	-148.35%-2.79B
Net common stock issuance	--0	35.57%-5.16B	--0	-583.76%-4B	---905M	95.00%-250M	-27.26%-8B	12.18%-2.42B	-11.43%-585M	--0
Cash dividends paid	-1.34%-1.21B	-2.37%-4.74B	-1.31%-1.16B	-3.21%-1.19B	-4.09%-1.2B	-0.93%-1.2B	-5.41%-4.63B	-4.19%-1.15B	-5.87%-1.15B	-4.64%-1.15B
Proceeds from stock option exercised by employees	-5.43%-97M	-97.26%27M	-86.03%25M	-22.64%41M	-87.35%53M	-127.63%-92M	53.51%984M	--179M	--53M	--419M
Cash from discontinued financing activities
Financing cash flow	580.13%14.64B	44.49%-9.42B	129.79%967M	-13.58%-5.16B	38.27%-2.17B	46.05%-3.05B	-4.55%-16.96B	18.17%-3.25B	-155.22%-4.54B	-10.62%-3.52B
Net cash flow
Beginning cash position	23.53%11.52B	-34.86%9.33B	-4.89%7.57B	-23.13%8.43B	-28.07%9.05B	-34.86%9.33B	-4.39%14.32B	-42.67%7.96B	-3.83%10.96B	11.11%12.58B
Current changes in cash	-637.93%-2.14B	143.34%2.15B	204.24%3.87B	72.11%-819M	60.27%-615M	83.39%-290M	-793.33%-4.96B	159.27%1.27B	-217.01%-2.94B	-2,768.97%-1.55B
Effect of exchange rate changes	-446.15%-45M	236.36%45M	-17.89%78M	42.42%-38M	88.73%-8M	44.44%13M	67.65%-33M	275.93%95M	-135.71%-66M	-494.44%-71M
End cash Position	3.16%9.33B	23.53%11.52B	23.53%11.52B	-4.89%7.57B	-23.13%8.43B	-28.07%9.05B	-34.86%9.33B	-34.86%9.33B	-42.67%7.96B	-3.83%10.96B
Free cash flow	-5.27%2.55B	5.88%12.65B	32.50%3.92B	28.17%4.41B	-18.15%1.63B	-24.36%2.69B	-21.57%11.95B	-20.79%2.96B	-31.14%3.44B	-30.21%1.99B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall